Insights

  

Advances in the Management of Alzheimer


Drs Ronald C. Petersen and Alireza Atri provide a historical overview on the management of Alzheimer disease and comment on the likelihood of seeing new therapy emerge for the condition in the near future.

Ronald C. Petersen, MD, PhD, discusses the relationship between genetics and the risk for developing Alzheimer disease, as well as highlights efforts of the Generation Program.

An in-depth review of mechanisms linked to the pathogenesis of Alzheimer disease, including amyloid and tau.

Moving forward following failed studies in Alzheimer disease and improving how the condition is managed in the future.

Expert clinicians highlight current unmet needs surrounding the treatment of Alzheimer disease.
 

The role of clinical trials and the importance of counseling patients on trial enrollment and lifestyle interventions in the management of Alzheimer disease.

Drs Alireza Atri and Ronald C. Petersen remark on the important roles a community neurologist, as well as other members of a patient’s health care team, can play in the management of Alzheimer disease.

The rationale for investigating monoclonal antibodies and BACE inhibitors for the treatment of patients with Alzheimer disease.

Experts discuss the status of clinical trials that explore various monoclonal antibody therapies and BACE inhibitors for the treatment of Alzheimer disease.

An overview of exciting, upcoming therapies that may be of interest for the treatment of Alzheimer disease.

Considerations for improving upon the diagnosis and management of Alzheimer disease.
 
SAP Partner Banner